Clinical research, like many industries, has become increasingly globalized during the 21st century. Emerging markets in Asia and South America offer access to diverse patient populations, a greater number of subjects for recruitment, more opportunity for global collaboration and increased inclusivity. The globalization of clinical trials reflects a dynamic and interconnected approach to advancing medical
The US Food and Drug Administration (FDA) has granted approval to GlaxoSmithKline (GSK) for Arexvy, the world’s first vaccine designed to protect older adults against respiratory syncytial virus (RSV). RSV is a common respiratory virus that can cause serious illness, particularly in adults over 65 years of age, and in infants and young children. It
Canada has a rich history of involvement in medical research, spanning from early discoveries in the 19th century to groundbreaking advances in the 21st. The country has been, and continues to be home to numerous influential scientists, physicians, and researchers who have made significant impacts on the field of medicine. One of Canada’s most notable
Welcome to our latest blog series, created in recognition of Clinical Trials Day; an annual event observed on May 20th to commemorate the first randomized clinical trial conducted by James Lind in 1747. This day serves as an opportunity to recognize the vital role that clinical trials play in advancing medical research and improving patient
Diabetes research is coming to Stouffville! This fall, Stouffville Medical Centre will host its first clinical trial for type 2 diabetes, for people who have been diagnosed within the past 4 years. JoinAStudy.ca Principal Investigator Dr. Nima Mirtorabi and the medical team in Stouffville are excited to be contributors to the next wave of diabetes
JoinAStudy.ca Investigators Dr. Peter Dzongowski, Dr. Michael Jones and Dr. Sean Peterson were all recently involved in GSK trial AReSVi 006, evaluating a vaccine candidate for Respiratory Syncytial Virus (RSV). Recruitment was highly successful for all three investigators, whose work has helped lead to the first RSV vaccine candidate to show statistically significant and clinically
Researchers have found that bilingualism can slow down and mitigate the course of age-related changes in the human brain. The study is authored by scientists from the Institute of Cognitive Neuroscience in Moscow, Vita-Salute San Raffaele University in Milan and Northumbria University in Newcastle. A sample of cognitively healthy senior (60+ years of age) bilingual
JoinAStudy.ca Investigator Dr. Anil Gupta was recently asked to assist in the presentation of strategies for preventing COVID progression and transmission in the outpatient setting, including the latest therapeutic developments. This effort was supported by an educational grant from Merck Sharp & Dohme Corp. The presentation linked below will define the sub-populations that are most
Canada has approved the first oral COVID-19 treatment that can be taken at home. The drug, an antiviral developed by Pfizer, was found to reduce risk of hospitalization and death by 89 percent in clinical trials. At the moment, there is a “limited global supply” of the drug, thus Canadian health officials have prioritized the
Earlier this year, we reported on the positive findings of a Covid-19 treatment study, conducted by lead study author and JoinAStudy Investigator Dr. Anil Gupta. We are now proud to highlight that as of November 18, 2021 this research has been published in the prestigious New England Journal of Medicine. It is among the most reputable peer-reviewed medical
